actbiotechАктуальная биотехнологияTopical biotechnology2304-4691ВГУИТ10.20914/2304-4691-2022-1-82-85actbiotech-330Research ArticleСтатьиМИЦЕЛЛЯРНЫЕ СТРУКТУРЫ НА ОСНОВЕ ГИДРОФОБИЗИРОВАННОЙ ГИАЛУРОНОВОЙ КИСЛОТЫ ДЛЯ КОНСТРУИРОВАНИЯ ЛЕКАРСТВЕННЫХ ФОРМЕрмоленкоЮ. В.noemail@neicon.ruАнтоноваМ. М.noemail@neicon.ruМалковаК. В.noemail@neicon.ruСоловьеваИ. Н.noemail@neicon.ruГельперинаС. Э.noemail@neicon.ruРоссийский химико-технологический университет им. Д.И. МенделееваRussian Federation202226092022018285Copyright © Ермоленко Ю.В., Антонова М.М., Малкова К.В., Соловьева И.Н., Гельперина С.Э., 20222022Ермоленко Ю.В., Антонова М.М., Малкова К.В., Соловьева И.Н., Гельперина С.Э.Ермоленко Ю.В., Антонова М.М., Малкова К.В., Соловьева И.Н., Гельперина С.Э.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.actbio-vsuet.ru/jour/article/view/330ReferencesM.L. Adams, A. Lavasanifar, G.S. Kwon, Amphiphilic block copolymers for drug delivery, Journal of Pharmaceutical Sciences, 2003,92, 7, 1343-1355,M.L. Adams, A. Lavasanifar, G.S. Kwon, Amphiphilic block copolymers for drug delivery, Journal of Pharmaceutical Sciences, 2003,92, 7, 1343-1355,A. Passi, D. Vigetti, Hyaluronan as tunable drug delivery system, Advanced Drug Delivery Reviews, 2019, 13, 3. D. Smejkalová, T. Muthny, K. Nesporová, M. Hermannová, E. Achbergerova, G. Huerta-Angeles, M. Svoboda, M. Cepa, V.A. Passi, D. Vigetti, Hyaluronan as tunable drug delivery system, Advanced Drug Delivery Reviews, 2019, 13, 3. D. Smejkalová, T. Muthny, K. Nesporová, M. Hermannová, E. Achbergerova, G. Huerta-Angeles, M. Svoboda, M. Cepa, V.Machalová, D. Luptáková, V. Velebny, Hyaluronan polymeric micelles for topical drugdelivery, Carbohydrate Polymers, 2017. 156, 86-96, 4. L. Mayol, M. Biondi L. Russo, B.M. Mall, Kh. Schwach-Abdellaoui, Assunta Borzacchiello, Amphiphilic hyaluronic acid derivatives toward the design of micellesfor the sustained delivery of hydrophobic drugs, Carbohydrate Polymers, 2014, 102, 110- 116Machalová, D. Luptáková, V. Velebny, Hyaluronan polymeric micelles for topical drugdelivery, Carbohydrate Polymers, 2017. 156, 86-96, 4. L. Mayol, M. Biondi L. Russo, B.M. Mall, Kh. Schwach-Abdellaoui, Assunta Borzacchiello, Amphiphilic hyaluronic acid derivatives toward the design of micellesfor the sustained delivery of hydrophobic drugs, Carbohydrate Polymers, 2014, 102, 110- 116A. Passi, D. Vigetti, Hyaluronan as tunable drug delivery system, Advanced Drug Delivery Reviews, 2019, 13A. Passi, D. Vigetti, Hyaluronan as tunable drug delivery system, Advanced Drug Delivery Reviews, 2019, 13D. Smejkalová, T. Muthny, K. Nesporová, M. Hermannová, E. Achbergerova, G. Huerta-Angeles, M. Svoboda, M. Cepa, V. Machalová, D. Luptáková, V. Velebny, Hyaluronan polymeric micelles for topical drugdelivery, Carbohydrate Polymers, 2017. 156,D. Smejkalová, T. Muthny, K. Nesporová, M. Hermannová, E. Achbergerova, G. Huerta-Angeles, M. Svoboda, M. Cepa, V. Machalová, D. Luptáková, V. Velebny, Hyaluronan polymeric micelles for topical drugdelivery, Carbohydrate Polymers, 2017. 156,L. Mayol, M. Biondi L. Russo, B.M. Mall, Kh. Schwach-Abdellaoui, Assunta Borzacchiello, Amphiphilic hyaluronic acid derivatives toward the design of micellesfor the sustained delivery of hydrophobic drugs, Carbohydrate Polymers, 2014, 102, 110-L. Mayol, M. Biondi L. Russo, B.M. Mall, Kh. Schwach-Abdellaoui, Assunta Borzacchiello, Amphiphilic hyaluronic acid derivatives toward the design of micellesfor the sustained delivery of hydrophobic drugs, Carbohydrate Polymers, 2014, 102, 110-D. Šmejkalová, K. Nešporová, M. Hermannová, G. Huerta-Angeles, D. Cožíková, L. Vištejnová, B. Šafránková, Paclitaxel isomerisation in polymeric micelles based on hydrophobized hyaluronic acid, International Journal of Pharmaceutics, 2014, 466, 2014, 147-145.D. Šmejkalová, K. Nešporová, M. Hermannová, G. Huerta-Angeles, D. Cožíková, L. Vištejnová, B. Šafránková, Paclitaxel isomerisation in polymeric micelles based on hydrophobized hyaluronic acid, International Journal of Pharmaceutics, 2014, 466, 2014, 147-145.
The authors declare that there are no conflicts of interest present.